Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Arthritis meds and COVID: do they weaken your immune defense?

NCT ID NCT04584541

First seen Apr 01, 2026 · Last updated Jun 17, 2026 · Updated 10 times

Summary

This study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body fights a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on the same treatments. The goal was to measure virus levels and immune responses, but the study was stopped early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cochin hospital

    Paris, 75014, France

Conditions

The condition(s) this trial relates to.

COVID-19 rheumatoid arthritis Spondylarthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.